Sweet syndrome as an adverse reaction to tyrosine kinase inhibitors: A review-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Sweet syndrome as an adverse reaction to tyrosine kinase inhibitors: A review

Published:2020-11-05 Issue:1 Volume:34 Page:
ISSN:1396-0296
Container-title:Dermatologic Therapy
language:en
Short-container-title:Dermatologic Therapy

Author:

Yang Jason J.¹^ORCID,Maloney Nolan J.²^ORCID,Nguyen Kevin A.¹,Worswick Scott³,Smogorzewski Jan⁴,Bach Daniel Q.¹

Affiliation:

1. Division of Dermatology, Department of Medicine David Geffen School of Medicine at UCLA Los Angeles California USA

2. Department of Dermatology Stanford University School of Medicine Palo Alto California USA

3. Department of Dermatology Keck School of Medicine at the University of Southern California Los Angeles California USA

4. Division of Dermatology Harbor‐UCLA Medical Center Torrance California USA

Publisher

Wiley

Subject

Dermatology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dth.14461

Reference50 articles.

1. FDA-approved small-molecule kinase inhibitors

2. AdamsJA.Kinetic and catalytic mechanisms of protein kinases.https://doi.org/10.1021/cr000230w

3. Role of Tyrosine Kinase Inhibitors in Cancer Therapy

4. Small Molecule Tyrosine Kinase Inhibitors in the Treatment of Solid Tumors: An Update of Recent Developments

5. Kinase-targeted cancer therapies: progress, challenges and future directions

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cutaneous adverse reactions resulting from targeted cancer therapies: histopathologic and clinical findings;Human Pathology;2023-10

2. Drug‐induced Sweet's syndrome: A case/non‐case study in the French pharmacovigilance database;British Journal of Clinical Pharmacology;2023-08-28

3. Giant cellulitis-like Sweet syndrome in association with chronic myeloid leukemia;JAAD Case Reports;2023-04

4. Immune-related adverse events of cancer immunotherapies targeting kinases;Pharmacology & Therapeutics;2022-09

5. Neutrophilic Dermatoses: a Clinical Update;Current Dermatology Reports;2022-03-16

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3